Contribution of Pharmaceutical Care to Person-centered Health Care and the Safety of Pharmacotherapy for Hospitalized Older Individuals in Brazil: An Investigative Single-arm Intervention Trial

Author:

de Oliveira Alan Maicon1ORCID,Varallo Fabiana Rossi1ORCID,Rodrigues João Paulo Vilela1ORCID,Aguilar Guilherme José2ORCID,da Costa Lima Nereida Kilza3ORCID,Leira Pereira Leonardo Régis1ORCID

Affiliation:

1. School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.

2. Faculty of Philosophy, Sciences and Letters, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.

3. School of Medicine of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.

Abstract

Background: Adverse drug events (ADE) and medication errors (ME) provide large numbers of victims. Older people are more susceptible to these events, due to the continuing search for several chronic degenerative disease treatments. The Third Global Patient Safety Challenge announced the objective of reducing unnecessary polypharmacy, encouraging deprescription, and aiming to ensure the prescription of medications in an appropriate manner, based on the best evidence and taking into account the individual factors of people. Objective: To evaluate whether the Pharmaceutical Care (PC), when inserted in a geriatric ward and in the context of person-centered health care, cooperates with the safety of pharmacotherapy in older individuals in Brazil. Methods: This is an investigative, single-arm, preliminary study. Inclusion criteria: individuals aged ≥60 years and admitted in the geriatric ward between August 2019 to January 2020. The PC (with the practice of pharmacotherapeutic follow-up, medication reconciliation, and pharmacotherapy review) was made available to identifying ADE and ME, as well as the associated factors and clinical outcomes, were analyzed. Results: 60 participants were included. It was found that, on hospital admission, 93.3% of them were polymedicated and 86.7% had a history of using potentially inappropriate medications (PIM). ADE and ME were detected in 43 individuals (71.7%) and, in total, 115 incidents were identified, with drugs that act on the nervous system associated with them (31.9%). Acceptance of the PC's recommendations reached the rate of 85.2%. Polypharmacy (p=0.03) and the presence of multiple diseases (p=0.03) had effect on the presentation of ADE and ME. The number of medications in use decreased in the comparison between admission and hospital discharge (p<0.0001). Conclusion: This investigative study indicated that ADE and ME are linked to the polypharmacy in use at the beginning of hospitalization. On the other hand, we showed that the PC (inserted in the multidisciplinary team) contributed to the deprescribing of medications at hospital discharge. Therefore, the PC can provide improvements in this scenario. Trial registration: Brazilian Registry of Clinical Trials (registration number: RBR-34f2px4).

Funder

Coordination for the Improvement of Higher Education Personnel

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference42 articles.

1. Defense of Human Rights National Secretariat for the Promotion and Defense of Human Rights Data on aging in Brazil National Promotion Secretariat2015

2. Ramos L.R.; Garcia J.T.; Self-medication in elderly reidents in compinas Sao Oaulo, Brazil, Prevalence and associated factors Terapêutica medicamentosa no idoso 2007

3. Ghibelli S.; Marengoni A.; Djade C.D.; Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck(®)). Drugs Aging 2013,30(10),821-828

4. Medication safety in polypharmacy: Technical report World Health Organization2019

5. Munck AKR; Assessment of inappropriate medications prescribed for elderly patients in a University Hospital. HU Magazine 2014,38(3e4)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3